Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
EMBO Molecular Medicine|June 1, 2021
miR-9 modulates and predicts the response to radiotherapy and EGFR inhibition in HNSCCFrancesca Citron, Ilenia Segatto, Lorena Musco, et al.
Cell Reports. Medicine|February 18, 2026
Syndecan-1-targeted therapeutic antibody impairs macropinocytosis and elicits antitumor immunity in pancreatic cancerZecheng Yang, Madelaine S Theardy, Shuaitong Chen, et al.
Cancer Discovery|May 15, 2016
In Vivo Genetic Screens of Patient-Derived Tumors Revealed Unexpected Frailty of the Transformed PhenotypeDaniela Bossi, Angelo Cicalese, Gaetano I Dellino, et al.
JCI Insight|September 27, 2019
YAP1 oncogene is a context-specific driver for pancreatic ductal adenocarcinomaBo Tu, Jun Yao, Sammy Ferri-Borgogno, et al.
Cancer Research|November 7, 2020
Loss of ARID1A Promotes Epithelial-Mesenchymal Transition and Sensitizes Pancreatic Tumors to Proteotoxic StressHideo Tomihara, Federica Carbone, Luigi Perelli, et al.
Cancer Research|September 8, 2019
Predictive Signatures Inform the Effective Repurposing of Decitabine to Treat KRAS-Dependent Pancreatic Ductal AdenocarcinomaCarla Mottini, Hideo Tomihara, Diego Carrella, et al.
Biorxiv : the Preprint Server for Biology|October 3, 2023
Evolutionary fingerprints of EMT in pancreatic cancersLuigi Perelli, Li Zhang, Sarah Mangiameli, et al.
Pageof 7